Need for antibiotics · children aged up to 16 years with ARTIs
Homeopathic medicinal products (individualised treatment) showed no clear difference in need for antibiotics compared with placebo or usual care (low certainty).
1 finding from 1 review
Adverse events · children aged up to 16 years with ARTIs
Homeopathic medicinal products (individualised treatment) showed no clear difference in adverse events compared with placebo or usual care (moderate certainty).
1 finding from 1 review
Disease severity · children aged up to 16 years with ARTIs
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Recurrence of ARTI · children aged up to 16 years with ARTIs
Homeopathic medicinal products (non‐individualised treatment) showed no clear difference in recurrence of ARTI compared with placebo or usual care (low certainty).
1 finding from 1 review
Days off work for parents · children aged up to 16 years with ARTIs
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Need for antibiotics · children aged up to 16 years with ARTIs
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relapse · children under 18 years of age with enteric fever
It is very uncertain whether ceftriaxone changes relapse compared with azithromycin (very low certainty).
1 finding from 1 review
Time to defervescence · children under 18 years of age with enteric fever
Ceftriaxone showed no clear difference in time to defervescence compared with azithromycin (low certainty).
1 finding from 1 review
Length of hospital stay · children under 18 years of age with enteric fever
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · children under 18 years of age with enteric fever
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical failure · children under 18 years of age with enteric fever
Ceftriaxone showed no clear difference in clinical failure compared with azithromycin (low certainty).
1 finding from 1 review
Microbiological failure · children under 18 years of age with enteric fever
It is very uncertain whether ceftriaxone changes microbiological failure compared with azithromycin (very low certainty).
1 finding from 1 review
Participants' health status and well‐being · Indigenous children aged < 5 years
1 finding from 1 review
Psychological health and emotional behaviour of children Timing: the longest time point available for each study Direction of effect: higher beneficial · Indigenous children aged < 5 years
1 finding from 1 review
Physical health and developmental health outcomes of children Timing: the longest time point available for each study Direction of effect: higher beneficial · Indigenous children aged < 5 years
1 finding from 1 review
Family health‐enhancing lifestyle or behavioural outcomes Timing: the longest time point available for each study Direction of effect: higher beneficial · Indigenous children aged < 5 years
1 finding from 1 review
Psychological health of parent/carer Timing: the longest time point available for each study Direction of effect: higher beneficial · Indigenous children aged < 5 years
1 finding from 1 review
Harms · Indigenous children aged < 5 years
1 finding from 1 review
Objective measures of sleep · children between the ages of 1 month and 18 years who were admitted to a pediatric inpatient setting from another location
1 finding from 1 review
Participant or parent satisfaction · children between the ages of 1 month and 18 years who were admitted to a pediatric inpatient setting from another location
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found